Agilent Technologies (NYSE:A – Get Free Report) was upgraded by equities researchers at Barclays from an “underweight” rating ...
Agilent Technologies, Inc. (NYSE:A – Get Free Report) has received a consensus recommendation of “Hold” from the fourteen ratings firms that are currently covering the stock, Ratings reports. One ...
--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE ... the link on the Events section of Agilent’s investor relations website. A recording of the call also will be available on the website ...
The global nucleic acid testing market is witnessing unprecedented growth, with a market size of USD 3.7 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 6.8%. By the end of ...
GFP, expanding its portfolio of secondary antibodies for life science research. GFP is widely used to monitor protein ...
The global drug designing tools market is poised for significant expansion, anticipated to grow at a steady Compound Annual Growth Rate (CAGR) of 8.7% from 2023 to 2033. According to industry experts, ...
Bit Digital, Inc. ("Bit Digital" or the "Company"), a global platform for high-performance computing ("HPC") infrastructure and digital asset production headquartered in New York, today announced a ...
Shares of Agilent Technologies Inc. A slid 2.59% to $138.08 Wednesday, on what proved to be an all-around poor trading ...
2d
Fintel on MSNBarclays Upgrades Agilent Technologies (A)Fintel reports that on February 10, 2025, Barclays upgraded their outlook for Agilent Technologies (NYSE:A) from Underweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results